Join Dr. Steve Flamm, Director of Transplantation Services for the Liver Unit at Rush University in Chicago, as he hosts a vital discussion on steatotic liver disease (MASH). In this insightful episode, Dr. Flamm is joined by Dr. Kim Brown and Dr. Nancy Reau to explore the evolving landscape of fatty liver disease treatment. They discuss the change in terminology from NASH to MASH, the clinical implications of metabolic components in liver disease, and the latest advancements in therapy. Learn about the significance of fibrosis testing, the challenges in managing metabolic conditions, and the impact of new medications on patient care.

Join us for an enlightening discussion on Health-Related Quality of Life and emerging therapies in PBC. In this episode, leading experts Paul Kwo, MD, and John Vierling, MD share their insights on the latest advancements in PBC treatment and how these therapies can significantly impact patients' quality of life.